Considering the advantage of combined CEA and CA19–9 for colon cancer diagnosis [35], and the profile of serum TC and HDL in patients observed in this study, we assumed that the combination of cancer antigens and serum lipids could serve as a more effective marker for the diagnosis of colon cancer. The gene discussed is CEACAM5; the disease is cancer.